DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on August 14, 2008; DOI: 10.1124/dmd.108.022640


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.108.022640v1
36/11/2371    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tu, Y.
Right arrow Articles by Szklarz, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tu, Y.
Right arrow Articles by Szklarz, G. D.


Received for publication June 2, 2008.
Revised August 12, 2008.
Accepted for publication August 13, 2008.

The Application of Molecular Modeling for Prediction of Substrate Specificity in Cytochrome P450 1A2 Mutants

Youbin Tu 1, Rahul Deshmukh 1, Meena Sivaneri 1, Grazyna D. Szklarz 1*

1 West Virginia University

* Address correspondence to: E-mail: gszklarz{at}hsc.wvu.edu

Abstract

Molecular dynamics (MD) simulations of 7-ethoxy and 7-methoxyresorufin bound in the active site of P450 1A2 wild type and various mutants were used to predict changes in substrate specificity of the mutants. A total of 26 multiple mutants representing all possible combinations of five key amino acid residues which are different between P450 1A1 and 1A2, were examined. The resorufin substrates were docked in the active site of each enzyme in the productive binding orientation and MD simulations were performed on the ES complex. Ensembles collected from MD trajectories were then scored based on geometric parameters relating substrate position with respect to the activated oxoheme cofactor. The results showed a high correlation between the previous experimental data on P450 1A2 wild type and single mutants with respect to the ratio between 7-ethoxyresorufin-O-deethylase (EROD) and 7-methoxyresorufin-O-demethylase (MROD) activities, and the equivalent in silico E/M scores. Moreover, this correlation served to establish linear regression models utilized to evaluate E/M scores of multiple P450 1A2 mutants. Seven mutants, all of them incorporating the L382V substitution, were predicted to shift specificity to that of P450 1A1. The predictions were then verified experimentally. The appropriate P450 1A2 multiple mutants were constructed by site-directed mutagenesis, expressed in E. coli, and assayed for EROD and MROD activities. Out of six mutants, five demonstrated increased EROD/MROD ratio confirming modeling predictions.


Key words: computational models, computer modeling and simulation, CYP1A, cytochrome P450, cytochrome P450 catalyzed oxidations, cytochrome P450 function, cytochrome P450 isoforms, ligand docking, structure-activity relationships





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.